In several early cases of J&J vaccine blood clotting, patients were treated with heparin, which is a normal treatment for blood clots; however, in these cases the heparin worsened the situation. The pause helped educate hospitals and health systems going forward on how to treat similar symptoms in those with the J&J dose.
Researchers have begun to dig into the results of this data collection and identified trends that have helped them understand mortality rates during the pandemic and beyond. BD recently published two papers on specific data discoveries during COVID-19, and Kalvin Yu, MD, FIDSA, senior medical director with BD, discusses some of the key takeaways from that research.
Like many health systems developed through mergers and acquisitions, M Health Fairview sported consistent branding across what had previously been the Fairview Health and HealthEast Care systems, but it had a disparate array of back-end medical record systems behind the scenes.
For Maria Hernandez, president and CEO of Impact4Health, an organization that provides training and support for health systems around health equity, physicians may face a unique challenge in addressing the biases that can lead to this uneven treatment.
With chronic conditions accounting for seven of the top 10 causes of death worldwide and 90% of $3.8 trillion in U.S. annual healthcare costs, employers are wise to pay attention to this opportunity and look for ways to incorporate coaching into benefits packages.
During the Health Experience Design 2021 conference, Dennis Mihale, MD, chief medical officer for Upward Health, discussed lessons learned not only as an early adopter of telehealth in general, but also by having that advance familiarity when COVID-19 forced healthcare organizations across the world to reconsider their approach to telehealth.
Eliminating the technology that has complicated patient care is not an option, so health systems are searching for strategic technology deployments to address some of the challenges that have emerged. The results aim to bring physicians, nursing staff, and patients back into the realm of more meaningful interaction.
A study on transporting intensive care patients found that out of 262 transports, 26% had an adverse event—many of which were serious, including oxygen desaturation or hemodynamic instability. How can clinicians work to avoid these situations? And how can organizations leverage the electronic medical record (EMR) to analyze how and when they happen?
Radiomics is poised to be the next great advance. This relatively new technology enables healthcare and life science organizations to take traditional images, such as MRIs and PET scans, and use artificial intelligence to extract hundreds of data points about the biology of a tumor or lesion.
Many studies have shown the benefits of certain medications for improving long-term outcomes in patients with chronic conditions. However, even when evidence-based recommendations are closely followed, there is a potential for adverse consequences because of the concurrent use of multiple medications.